NCT06274788 2025-09-05
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
Fresenius Kabi
Recruiting
Fresenius Kabi
Fresenius Kabi
Hospices Civils de Lyon
Case Comprehensive Cancer Center